Sharp Mary Birch Hospital for Women & Newborns, San Diego, CA Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01720667
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Sharp Mary Birch Hospital for Women & Newborns

Active Ingredients

Drugs in Phase 3 Trials (3)

ampicillin (1 trial)

gentamicin (garamycin) (1 trial)

ibuprofen (motrin) (1 trial)

Drugs in Phase 2 Trials (2)

levetiracetam (keppra) (2 trials)

phenobarbital (Luminal) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Seizures (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5